CONMED (CNMD) News Today

UniSuper Management Pty Ltd bought a new position in shares of CONMED Co. (NYSE:CNMD - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,401 shares of the company's stock, valued at approxim

Needham & Company LLC reduced their price target on CONMED from $107.00 to $106.00 and set a "buy" rating on the stock in a research report on Thursday.

Thornburg Investment Management Inc. boosted its position in CONMED Co. (NYSE:CNMD - Free Report) by 35.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 111,667 shares of the company's stock after b

Clearbridge Investments LLC acquired a new stake in CONMED Co. (NYSE:CNMD - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 341,440 shares of the company's stock, valued at approximately $27,343,000. Clearbr

Lord Abbett & CO. LLC lessened its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 96.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 147,620 shares of the company's stock after selling 4,633,238 shares during

BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its stake in CONMED Co. (NYSE:CNMD - Free Report) by 22.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 317,994 shares of the company's stock after buying an additiona

Quantbot Technologies LP purchased a new stake in CONMED Co. (NYSE:CNMD - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 16,252 shares of the company's stock, valued at approximately $1,301,000. Quantbot Technologies LP

Duality Advisers LP raised its stake in shares of CONMED Co. (NYSE:CNMD - Free Report) by 149.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,541 shares of the company's stock after acquiring an add

CONMED (NYSE:CNMD) Stock Price Down 3.8%

AMI Asset Management Corp raised its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 31.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 55,728 shares of the company's stock after purchasing an additional

Vanguard Group Inc. cut its stake in shares of CONMED Co. (NYSE:CNMD - Free Report) by 0.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,420,011 shares of the company's stock after selling 20,448 shares during the p

Mountain Pacific Investment Advisers Inc. ID increased its stake in CONMED Co. (NYSE:CNMD - Free Report) by 29.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 248,304 shares of the company's stock after purchasing an a

Fisher Asset Management LLC cut its holdings in CONMED Co. (NYSE:CNMD - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 278,134 shares of the company's stock after selling 25,162 sha

CONMED Co. (NYSE:CNMD - Get Free Report) insider Stanley W. Peters III sold 4,000 shares of the stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $71.82, for a total value of $287,280.00. Following the completion of the transaction, the insider now owns 63 shares in the company, valued at approximately $4,524.66. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Congress Asset Management Co. MA lifted its position in shares of CONMED Co. (NYSE:CNMD - Free Report) by 8.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 302,467 shares of the company's stock after acqu

CONMED Co. (NYSE:CNMD - Get Free Report) has earned an average recommendation of "Moderate Buy" from the six ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the com

Intrinsic Edge Capital Management LLC boosted its position in shares of CONMED Co. (NYSE:CNMD - Free Report) by 672.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 77,248 shares of the company's s

Sectoral Asset Management Inc. cut its position in shares of CONMED Co. (NYSE:CNMD - Free Report) by 84.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,100 shares of the company's stock after selling 95,900 shares during the qua

Campbell & CO Investment Adviser LLC cut its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 68.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,828 shares of the company's stock after selling 14,644

Capital Research Global Investors grew its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 11.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,757,108 shares of the company's stock after buying an additional 289,996 sh

CONMED Co. (NYSE:CNMD - Get Free Report) was the target of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 3,660,000 shares, an increase of 5.2% from the April 30th total of 3,480,000 shares. Based on an average daily trading volume, of 520,800 shares, the days-to-cover ratio is currently 7.0 days.

Dimensional Fund Advisors LP increased its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 5.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 712,332 shares of the company's stock after purch

CONMED Co. (NYSE:CNMD) announced a quarterly dividend on Wednesday, May 22nd. Shareholders of record on Friday, June 14th will be given a dividend of 0.20 per share on Friday, July 5th. This represents a $0.80 annualized dividend and a yield of 1.09%. The ex-dividend date of this dividend is Friday, June 14th.

CONMED Co. (NYSE:CNMD - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The ave

Principal Financial Group Inc. trimmed its stake in CONMED Co. (NYSE:CNMD - Free Report) by 2.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 600,334 shares of the company's stock after selling 13,021 shares dur

CONMED Co. (NYSE:CNMD - Get Free Report) Director Barbara J. Schwarzentraub purchased 1,442 shares of CONMED stock in a transaction that occurred on Wednesday, May 8th. The stock was acquired at an average price of $69.26 per share, with a total value of $99,872.92. Following the transaction, the director now owns 1,442 shares in the company, valued at $99,872.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

CONMED Co. (NYSE:CNMD - Get Free Report) Director Martha Goldberg Aronson bought 2,000 shares of the firm's stock in a transaction dated Monday, May 6th. The shares were acquired at an average price of $70.98 per share, for a total transaction of $141,960.00. Following the completion of the transaction, the director now directly owns 2,000 shares in the company, valued at approximately $141,960. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Lisanti Capital Growth LLC purchased a new position in shares of CONMED Co. (NYSE:CNMD - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 40,570 shares of the company's stock, valued at approximately $4,443,0

Needham & Company LLC restated a "buy" rating and issued a $107.00 price target on shares of CONMED in a research note on Monday.

Fisher Asset Management LLC lowered its stake in shares of CONMED Co. (NYSE:CNMD - Free Report) by 8.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 277,809 shares of the company's stock

CONMED Co. (NYSE:CNMD - Get Free Report) COO Pat Beyer bought 3,000 shares of CONMED stock in a transaction on Tuesday, April 30th. The stock was acquired at an average cost of $68.30 per share, for a total transaction of $204,900.00. Following the acquisition, the chief operating officer now owns 10,807 shares in the company, valued at approximately $738,118.10. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Mountain Pacific Investment Advisers Inc. ID raised its position in CONMED Co. (NYSE:CNMD - Free Report) by 33.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 192,426 shares of the company's stock after purchasing a